As of April 2024 Ascendis Pharma has a market cap of $8.10 Billion. This makes Ascendis Pharma the world's 1869th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $8.10 B | 13.82% |
2023 | $7.12 B | 2.26% |
2022 | $6.96 B | -8.98% |
2021 | $7.65 B | -14.11% |
2020 | $8.90 B | 33.45% |
2019 | $6.67 B | 152.89% |
2018 | $2.63 B | 81.2% |
2017 | $1.45 B | 122.15% |
2016 | $0.65 B | 42.45% |
2015 | $0.46 B |
On Apr 23rd, 2024 the market cap of Ascendis Pharma was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Akebia Therapeutics AKBA | $0.28 B | -96.46% | ๐บ๐ธ USA |
Affimed
AFMD | $74.31 M | -99.08% | ๐ฉ๐ช Germany |
Advaxis ADXS | $23 M | -99.72% | ๐บ๐ธ USA |